| Literature DB >> 28919255 |
Sabrina Adorisio1, Alessandra Fierabracci2, Isabella Muscari3, Anna Marina Liberati3, Emira Ayroldi1, Graziella Migliorati1, Trinh Thi Thuy4, Carlo Riccardi1, Domenico V Delfino5.
Abstract
Small ubiquitin-like modifier (SUMO) proteins belong to the ubiquitin-like family and act to change the function of target proteins through post-translational modifications. Through their interactions with innate immune pathways, SUMOs promote an efficient immune response to pathogenic challenge avoiding, at the same time, an excess of immune response that could lead to the development of autoimmune diseases. This report discusses the general functions of SUMO proteins; highlights SUMO involvement in the innate immune response through their role in NF-κB and interferon pathways; the involvement of SUMO proteins in autoimmune diseases; and reviews bacterial, viral, and parasitic interactions with SUMO pathways. In conclusion, we speculate that targeting SUMOs could represent a new therapeutic strategy against infections and autoimmunity.Entities:
Keywords: Autoimmunity; Innate immune system; Interferon pathway; NF-κB pathway; Small ubiquitin-like modifier (SUMO) proteins
Mesh:
Substances:
Year: 2017 PMID: 28919255 DOI: 10.1016/j.jaut.2017.09.001
Source DB: PubMed Journal: J Autoimmun ISSN: 0896-8411 Impact factor: 7.094